Cellosaurus logo
expasy logo

Cellosaurus M019iCis (CVCL_JM65)

[Text version]
Cell line name M019iCis
Accession CVCL_JM65
Resource Identification Initiative To cite this cell line use: M019iCis (RRID:CVCL_JM65)
Comments Population: Caucasian.
Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
Omics: Deep exome analysis.
Omics: Deep phosphoproteome analysis.
Omics: Deep proteome analysis.
Omics: DNA methylation analysis.
Omics: Transcriptome analysis by RNAseq.
Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
Disease High grade ovarian serous adenocarcinoma (NCIt: C105555)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_JM64 (M019i)
Sex of cell Female
Age at sampling 63Y
Category Cancer cell line
Publications

PubMed=28455291; DOI=10.1074/mcp.M116.058321; PMCID=PMC5500768
Nguyen E.V., Huhtinen K., Goo Y.A., Kaipio K., Andersson N., Rantanen V., Hynninen J., Lahesmaa R., Carpen O., Goodlett D.R.
Hyper-phosphorylation of sequestosome-1 distinguishes resistance to cisplatin in patient derived high grade serous ovarian cancer cells.
Mol. Cell. Proteomics 16:1377-1392(2017)

PubMed=28473707; DOI=10.1038/s41598-017-01624-4; PMCID=PMC5431431
Lund R.J., Huhtinen K., Salmi J., Rantala J., Nguyen E.V., Moulder R., Goodlett D.R., Lahesmaa R., Carpen O.
DNa methylation and transcriptome changes associated with cisplatin resistance in ovarian cancer.
Sci. Rep. 7:1469-1469(2017)

Cross-references
Encyclopedic resources Wikidata; Q54903412
Proteomic databases PRIDE; PXD002394
Entry history
Entry creation22-Aug-2017
Last entry update19-Dec-2024
Version number6